JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced preliminary financial results for the second quarter of 2015: Revenues of approximately $4.97 billion, down 2% compared to the second quarter of 2014. Excluding the impact of foreign exchange fluctuations and the sale of U.S. OTC plants in July 2014, revenues increased 6% compared to the second quarter of 2014. Non-GAAP diluted earnings per share (EPS) of $1.43 in the second quarter of 2015, up
| < Prev | Next > |
|---|
